Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Bura-Rivière

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
La Revue Du Praticien|October 31, 2013
[New anticoagulants in the treatment of venous thromboembolism]Alessandra Bura-Rivière
La Revue Du Praticien|May 31, 2022
[Venous thromboembolic disease and cancer: 10 key messages]Alessandra Bura-Rivière
La Revue Du Praticien|December 15, 2012
[Thrombophilia and pregnancy]Alessandra Bura-Rivière
La Revue Du Praticien|December 5, 2018
[Atherosclerotic arterial disease of the lower limbs: a prevalence that increases significantly with age]Alessandra Bura-Rivière
Presse Medicale (Paris, France : 1983)|January 27, 2018
[Lower-extremity artery disease (LEAD)]Alessandra Bura-Rivière, Romain Martin
Presse Medicale (Paris, France : 1983)|June 4, 2014
[Lower limb occlusive arterial disease: Diagnosis problems in 2014]Joël Constans, Alessandra Bura-Rivière
European Journal of Clinical Pharmacology|December 19, 2023
Association of antidepressants plus antithrombotics and bleeding risk: a pharmacovigilance studyJean-Louis Montastruc, Alessandra Bura-Rivière
Fundamental & Clinical Pharmacology|October 7, 2025
Sex and Age Differences in Suspected Bleeding Reporting With Acetyl Salicylic Acid: A Descriptive Study in the Global Pharmacovigilance Database, VigibaseJean-Louis Montastruc, Alessandra Bura-Rivière
British Journal of Clinical Pharmacology|April 24, 2024
Bleeding in patients on concurrent treatment with serotonin reuptake inhibitor (SRI) and acetylsalicylic acid (ASA) compared with ASA alone: a pharmacovigilance studyJean-Louis Montastruc, Alessandra Bura-Rivière
La Revue Du Praticien|December 5, 2018
[Managing the atherosclerotic arterial disease]François-Xavier Lapébie, Alessandra Bura-Rivière
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
La Revue Du Praticien|October 31, 2013
[New anticoagulants in the treatment of venous thromboembolism]Alessandra Bura-Rivière
La Revue Du Praticien|May 31, 2022
[Venous thromboembolic disease and cancer: 10 key messages]Alessandra Bura-Rivière
La Revue Du Praticien|December 15, 2012
[Thrombophilia and pregnancy]Alessandra Bura-Rivière
La Revue Du Praticien|December 5, 2018
[Atherosclerotic arterial disease of the lower limbs: a prevalence that increases significantly with age]Alessandra Bura-Rivière
Presse Medicale (Paris, France : 1983)|January 27, 2018
[Lower-extremity artery disease (LEAD)]Alessandra Bura-Rivière, Romain Martin
Presse Medicale (Paris, France : 1983)|June 4, 2014
[Lower limb occlusive arterial disease: Diagnosis problems in 2014]Joël Constans, Alessandra Bura-Rivière
European Journal of Clinical Pharmacology|December 19, 2023
Association of antidepressants plus antithrombotics and bleeding risk: a pharmacovigilance studyJean-Louis Montastruc, Alessandra Bura-Rivière
Fundamental & Clinical Pharmacology|October 7, 2025
Sex and Age Differences in Suspected Bleeding Reporting With Acetyl Salicylic Acid: A Descriptive Study in the Global Pharmacovigilance Database, VigibaseJean-Louis Montastruc, Alessandra Bura-Rivière
British Journal of Clinical Pharmacology|April 24, 2024
Bleeding in patients on concurrent treatment with serotonin reuptake inhibitor (SRI) and acetylsalicylic acid (ASA) compared with ASA alone: a pharmacovigilance studyJean-Louis Montastruc, Alessandra Bura-Rivière
La Revue Du Praticien|December 5, 2018
[Managing the atherosclerotic arterial disease]François-Xavier Lapébie, Alessandra Bura-Rivière
Pageof 7